Johnson & Johnson appoints Dr. John Reed as EVP, Pharmaceuticals, R&D

Pfizer appoints Meenakshi Nevatia as MD and Additional Director

She is a seasoned leader with nearly 30 years of business leadership and consulting experience with top companies such as Mckinsey and Co, Novartis Pharmaceuticals and Stryker India Pvt. Ltd.

Windlas Biotech appoints Komal Gupta as CEO

The company is in the process of appointing the new Chief Financial Officer shortly and in the interim, Komal Gupta will continue as CFO

Global diagnostic imaging market to reach $31.9 billion in 2023: GlobalData

Diagnostic imaging will become an increasingly vital process in healthcare

Supriya Lifescience appoints Krishna Raghunathan as CFO

He was previously associated with renowned companies such as Granules India Ltd, Dr. Reddy’s Laboratories ltd & Aptar Group

Provention Bio appoints Rita Jain to Board of Directors

Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co

BeatO appoints Dr. Navneet Agrawal as Chief Clinical Officer

He has published more than 100 research papers in several prestigious national and international journals

AstraZeneca India appoints Dr. Sanjeev Panchal as Country President & MD

Sanjeev is currently the Country President for AstraZeneca Malaysia

Peter Bains appointed Additional Director of Biocon

He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels

Lupin appoints Spiro Gavaris as President of U.S. Generics Business

Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business